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Study objective. To compare patient satisfaction with emergency department (ED) opt-in and opt-out HIV screening. Methods.
We conducted a survey in an urban ED that provided rapid HIV screening using opt-in (February 1, 2007–July 31, 2007) and
opt-out (August 1, 2007–January 31, 2008) approaches. We surveyed a convenience sample of patients that completed screening in
each phase. The primary outcome was patient satisfaction with HIV screening. Results. There were 207 and 188 completed surveys
during the opt-in and opt-out phases, respectively. The majority of patients were satisﬁed with both opt-in screening (95%, 95%
conﬁdence interval [CI] = 92–98) and opt-out screening (94%, 95% CI = 89–97). Satisfaction ratings were similar between opt-in
and opt-out phases even after adjusting for age, gender, race/ethnicity, and test result (adjusted odds ratio 1.3, 95% CI = 0.5–3.1).
Conclusions. Emergency department patient satisfaction with opt-in and opt-out HIV screening is similarly high.
1.Introduction
1.1. Background. In 2006 the Centers for Disease Control
and Prevention (CDC) published revised recommendations
for HIV testing in health-care settings, which included emer-
gency departments (EDs) [1]. Prior to these recommenda-
tions, the standard approach included opt-in HIV screening
(in which patients are oﬀered an HIV test and assent is
required), separate written consent, and pre- and posttest
counseling. The revised recommendations include using an
opt-out approach to screening and removing requirements
for test counseling and separate written informed consent
as strategies to reduce barriers to testing and to make
testing a routine part of care. With opt-out HIV screening,
patients are notiﬁed that HIV testing will be performed
unless they decline and consent for testing is integrated
into the general ED consent process. Pretest counseling
and risk assessment are not recommended, and written
informational materials can replace posttest counseling and
risk reduction strategies for patients that test negative.
Access to clinical care and support services continue to
be essential for patients with positive HIV test results
[1].
The CDC recommends an opt-out approach for several
reasons. By integrating opt-out screening into general con-
sent, the screening process is streamlined and routinized.
Patients may perceive the process to be less stigmatizing
because they do not feel “singled out” for testing [1, 2]. It
is hoped that adopting opt-out screening methodologies will
increasescreeningrates.Thisissupportedbytheﬁndingthat,
in some clinical settings, screening rates are higher with opt-
out than with opt-in screening [3–6].
Despite the backing of the CDC and these initial clinical
successes, some experts cite concerns with an opt-out ap-
proach to HIV screening [2, 7–12]. These concerns include
inadequate patient preparation for testing, insuﬃcient pre-
test information and counseling, coercion to test, loss of
patient autonomy, and inappropriate testing of patients that
lack the capacity to consent.
Patient satisfaction and attitudes toward opt-out HIV
screening compared with opt-in HIV screening have not
been studied. Understanding the experience of patients with
opt-out screening is important for the successful integration
of the revised CDC guidelines. The goal of this study was to
comparepatientsatisfactionwithEDHIVscreeningusingan
opt-in versus an opt-out approach.2 AIDS Research and Treatment
2. Methods
2.1. Study Setting and Population. The study was conducted
at an urban teaching hospital and regional trauma center
in Oakland, California. In 2006, the annual ED census was
approximately 75,000 visits; 47% of patients presenting to
theEDwereblack,32%wereHispanic,21%werewhite,44%
were female, 98% were adults ≥15 years of age, and 80% did
not have health insurance.
2.2. Study Design. We conducted a survey study to compare
ED patient satisfaction and patient attitudes toward opt-in
and opt-out rapid HIV screening. This survey study was
administered concurrently with a prospective observational
study comparing the outcomes of two successive 6-month
screening periods. During the ﬁrst 6 months, nontarget-
ed opt-in HIV screening was performed and during the
second 6 months, nontargeted opt-out screening was per-
formed [13]. The medical center’s institutional review board
approved this study.
2.3. HIV Screening Protocol. A detailed description of the
HIV screening protocol has previously been published [14].
In brief, all ED patients ﬁrst completed a rapid triage nurse
assessment in the waiting room area. During both screening
phases,medicallystablepatients wereprovidedapretest HIV
informationbrochure(thatincludedinformationaboutHIV
transmission, rapid HIV testing, and risk reduction) and
were then referred to registration. After completing registra-
tion, patients were directed to the triage area for a standard
triage nurse evaluation prior to ED placement.
Twofull-timemedicalassistantswerehiredasHIVtesters
and worked during the entire study period. HIV testers
were located in a testing station within the triage area on
weekdays between 7am and 10pm. Only one HIV tester
was on duty at any given time. During hours when the
HIV tester was not on site, screening was not performed.
During both study phases, HIV testing was performed at the
testing station using the OraQuick ADVANCE Rapid HIV
1/2 Antibody Test (OraSure Technologies, Inc. Bethlehem,
PA, USA) on oral ﬂuid specimens. HIV test results were
documented in special ﬁelds in the electronic medical record
(Wellsoft Corporation, Somerset, NJ, USA) accessible by
clinical staﬀ. Results were interpreted as reactive, negative, or
indeterminate.
Patients were eligible for HIV screening if they were ≥15
years of age, medically stable, and able to consent for HIV
testing(opt-inphase)orabletocompletethegeneralconsent
for care (opt-out phase).
2.4. Nontargeted Opt-In Screening Phase (February 1, 2007–
July 31, 2007). During this phase, all medically stable pa-
tients were referred by the triage nurse to the HIV tester.
HIV testers determined eligibility and oﬀered HIV screening
using the following opt-in script: “Would you like to have
a rapid HIV test today?” Patients opting-in completed a
streamlined HIV consent form followed by immediate test-
ing. No additional counseling was performed, and patients
were directed to the waiting room after collection of an oral
ﬂuid sample.
2.5. Nontargeted Opt-Out Screening Phase (August 1, 2007–
January 31, 2008). During this phase, consent for HIV test-
ing was integrated into the general consent form for medical
care in accordance with CDC guidelines and California
state law and completed during registration. The general
ED consent form was modiﬁed to include both a statement
that HIV testing may be performed during the ED visit
unless the patient declined and an opt-out signature box
next to the statement, “I do not want to be HIV tested.”
Registration staﬀ determined eligibility and oﬀered HIV
screening using the following opt-out script: “HIV testing
may be performed during your emergency room visit, if you
do not want to be HIV tested sign here.” Patients declined
testing by signing in the opt-out signature box. Registration
staﬀ electronically ﬂagged the charts of patients not opting-
out and then referred these patients to the triage area where
rapid testing was performed by the HIV testers.
2.6. HIV Result Disclosure. In both study phases, HIV test
results were documented and provided to patients using the
sameproceduresandprintedmaterials.Aftertestswerecom-
pleted, the HIV testers placed an electronic order instructing
the nurse to disclose negative results once the patient was
placedintheED.Nursingstaﬀverballydisclosedthenegative
results and provided patients with a postresult informa-
tional handout that documented the result, explained risk
reduction strategies and indications for repeat testing, and
provided a list of testing resources. A copy of the postresult
handout was also added to the patient’s electronic discharge
instructions.
Patients who had reactive HIV test results were placed
immediately in a private room in the ED. HIV testers and ED
physicians provided patients with a verbal explanation of the
reactive test result, oﬀered emotional support, and arranged
direct linkage to follow-up care. A postresult informational
handout was also provided that explained the preliminary
nature of the test result, the importance of conﬁrmatory test-
ing and follow-up care, strategies to prevent transmission,
and referral for mental health and other support services.
Blood was drawn and sent for CD4 cell count, viral load, and
Western blot testing. Drop-in follow-up appointments were
availableonselectdatesandtimesatthemedicalcenter’sHIV
clinic.
2.7. Study Protocol. The survey instrument was developed by
one of the authors in collaboration with experts from the
CDC and an emergency medicine physician with experience
in ED-based rapid HIV testing (Appendix). The survey
instrument was pilot tested on a convenience sample of
patients (n = 10), and reﬁnements were made based on
feedback. The survey elicited demographic information,
including age, gender, race/ethnicity, education level, type of
health insurance, current relationship status, risk factors for
HIV, previous HIV testing, satisfaction with the screening
program, and attitudes toward the screening program. The
target population for survey administration was all screenedAIDS Research and Treatment 3
patients with reactive results and a convenience sample of
screened patients with negative results.
The survey was administered to English and Spanish
speaking patients with negative HIV screening tests during
the last three months of the opt-in and opt-out screening
phases (May 1, 2007–July 31, 2007 and November 1, 2007–
January 31, 2008), respectively. The two survey adminis-
trators were college research volunteers who were trained
in survey administration and who were not blinded to the
study purpose. Working in three-hour shifts, survey admin-
istrators reviewed the ED electronic record and identiﬁed
all patients who had completed HIV screening, received
their test results, and had not been discharged. Patients
were then approached, and eligible patients were provided
an explanation of why the study was being performed
and written informed consent was obtained. Patients were
ineligible for survey administration according to prespec-
iﬁed criteria: unavailable, too ill, language spoken other
than English/Spanish, or altered mental status/confusion.
Determination of eligibility was at the discretion of the
survey administrators. The survey was verbally administered
face-to-face at the patient’s bedside. In order to evaluate
the satisfaction and attitudes of patients with reactive HIV
screening tests, these patients were asked to participate in
the study as part of the result disclosure process. Surveys for
this subset of patients were conducted by a single research
coordinator.
2.8. Outcome Measures. The primary outcome measure was
overall satisfaction with opt-in and opt-out screening. The
global index of satisfaction was determined by asking the
patient, “Overall, how would you rate the rapid HIV testing
program in the emergency department?” Responses were
graded on a 5-point Likert scale (poor, fair, good, very good,
and excellent). Respondents were classiﬁed as satisﬁed with
theHIVtestingprogramiftheyratedtheprogramgood,very
good, or excellent and dissatisﬁed if they rated the program
poor or fair. Secondary outcome measures were the attitudes
of patients toward each screening program. The attitudes
of patients toward the screening program were evaluated
by assessing their level of agreement (agree, disagree) with
13 potential indicators of satisfaction over 6 domains. The
domains were designed to evaluate (1) patient satisfaction,
(2)coerciontotest,(3)impactoftestingoncarereceived,(4)
conﬁdentiality of screening, (5) information provided, and
(6) patient beliefs regarding the role of HIV screening.
2.9. Data Analysis. The research volunteers entered the
survey responses into a spreadsheet (Microsoft Excel 2003,
Microsoft Corporation, Redmond, WA, USA). The ﬁrst 25
surveys by each research volunteer were reviewed to ensure
accurate entry of responses, and inconsistent data were
identiﬁed and reconciled. The study population and results
ofthesatisfactionsurveyarereportedindescriptivestatistics.
Categorical data are reported as percentages with 95% conﬁ-
dence intervals (CIs). Frequencies of survey responses and
demographics were evaluated by screening program (opt-
in versus opt-out) using Chi-square analysis and Fisher’s
exacttests.Wespeciﬁedalogisticregressionmodeltopredict
responses to questions about patient satisfaction and patient
attitudes toward the opt-in and opt-out screening programs,
based on consent arm allocation and adjusting for the varia-
bles age, gender, race/ethnicity, and HIV test result, which,
because of each covariate’s theoretic importance in the
model, were included regardless of signiﬁcance in bivariate
testing. A priori sample size calculation was performed and
based on an opt-in satisfaction rate of 95% (pilot data), 159
patients per group were needed to determine an absolute
diﬀerence in satisfaction of 10% between opt-in and opt-
out screening, assuming a P value < 0.05 and power 80%.
All statistical analyses were performed using SPSS 16.0 (SPSS
Inc., Chicago, IL, USA).
3. Results
T h es t u d yﬂ o wi so u t l i n e di nFigure 1. For the opt-in
versus the opt-out screening phases, results were as follows:
there were 23,236 potentially eligible patients versus 26,757;
screening oﬀer rate was 27.9% (6,479/23,236) versus 75.8%
(20,280/26,757) (P<0.001); screening acceptance rate
was 62.7% (4,061/6,479) versus 30.9% (6,273/20,280) (P<
0.001); testing completion rate was 99.8% (4,053/4,061)
versus 74.6% (4,679/6,273) (P<0.001); overall screening
rate was 17.4% (4,053/23,236) versus 17.5% (4,679/26,757)
(P = 0.90).
During the opt-in phase, research volunteers approached
293 of the 4,053 patients that completed HIV screening to
participate in the survey. Of these, 208 were eligible and
207 consented and completed the survey. During the opt-
out phase, research volunteers approached 273 of the 4,679
patients that completed HIV screening to participate in the
survey. Of these, 190 were eligible and 188 consented and
completed the survey. Reasons patients were ineligible for
survey administration were similar between both phases and
included:patientunavailable(61%),languagebarrier(31%),
too ill (7%), and altered mental status/confusion (2%). Of
the 207 patients who completed surveys during the opt-in
phase,199(96%)testednegative and8(4%)hadreactivetest
results. Of the 188 patients who completed surveys during
the opt-out phase, 160 (85%) tested negative and 28 (15%)
had reactive test results.
Characteristics of patients accepting screening and char-
acteristics of patients surveyed in both opt-in and opt-
out HIV screening phases are shown in Table 1. Patients
accepting opt-in screening were similar to patients accepting
opt-out screening with respect to age and gender; however,
there were diﬀerences in race/ethnicity. There were no
diﬀerences with respect to age, race/ethnicity, education
level, HIV risk, or previous HIV testing between patients
surveyed during the opt-in and the opt-out phases; however
opt-out surveyed patients were more likely to be male,
uninsured, and single.
Patient satisfaction ratings were available for 393 of
the 395 surveyed patients and are shown in Table 2.O n e
patient testing negative in each phase chose the option
“prefer not to answer/I do not know” when asked to rate
their satisfaction. The majority of patients in the opt-
in phase (95.1%, 95% CI = 92.0–98.0) and the opt-out4 AIDS Research and Treatment
Opt-in HIV screening phase Opt-out HIV screening phase
February 1, 2007-July 31, 2007 August 1, 2007-January 31, 2008
23,236
Offered screening Offered screening
Accepted screening Accepted screening
Completed screening Completed screening
Eligible for survey Eligible for survey
Consented Consented
Negative
199
Negative
160
Reactive
8
Reactive
28
Approached for survey Approached for survey
6,479
4,061
4,053
293
208 190
188
273
4,679
6,273
20,280
26,757
207
85 ineligible for survey 83 ineligible for survey
53 patient unavailable 49 patient unavailable
25 language barrier 27 language barrier
5 too sick 6 too sick
2 altered mental status 1 altered mental status
Emergency department census† Emergency department census†
†Drawn from the emergency department census during HIV screening hours, weekdays between 7am and 10 pm.
Figure 1: Study ﬂow diagram.
phase (93.6%, 95% CI = 89.3–96.7) were satisﬁed with the
HIV screening program. A higher proportion of patients
who experienced opt-in screening rated the experience as
excellent rather than very good, as compared to the opt-
out ratings which were more frequently very good rather
than excellent. Overall satisfaction ratings remained similar
between opt-in and opt-out phases even after adjusting for
age,gender,race/ethnicity,andHIVtestresult(adjustedodds
ratio 1.3, 95% CI = 0.5–3.1, data not shown).
Responses to questions assessing patient attitudes toward
HIV screening are shown in Table 3. Among the domains,
most attitudes towards opt-in and opt-out screening were
similar. These similarities persisted after adjusting for age,
gender, race/ethnicity, and HIV test result. Although a signif-
icantly higher proportion of patients during the opt-in phase
would have liked additional discussion about HIV risk and
HIV prevention, most patients in both phases felt that the
information they were given about testing was adequate. The
majority of patients in both phases reported being satisﬁed
with the HIV testing received and would recommend the
ED as a place to get HIV tested. Patients completing opt-out
HIVscreeningdidnotreportfeelinganymorepressuredinto
testing and still felt like they had a choiceabout getting tested
when compared with patients completing opt-in screening.
Most patients also agreed that HIV testing did not interfere
with the overall care received and perceived the testing
process to be conﬁdential. Over 90% of patients in both
phases felt that HIV testing should be a regular part of health
care and that routine testing should be performed in the
ED.
4. Discussion
The CDC has called for “explicit and measurable indicators
to measure the progress on the process and outcomes” of
the revised recommendations [15]. Since release of the 2006
recommendations,threeEDstudieshavereportedonspeciﬁc
outcomes associated with opt-out screening, including the
number of persons tested, the number of patients receiving
HIV care as a result of screening, baseline CD4 count, and
number of false-positive screening test results [14, 16, 17].
This is the ﬁrst study to focus on patient satisfaction and
patient attitudes about HIV screening, and to compare these
outcomes between opt-in and opt-out screening programs.
Patient satisfaction with ED-based HIV screening may be
an important determinant of a program’s success. Not only
maypatientsatisfactioninﬂuenceacceptanceratesbutitmay
also aﬀect the willingness of administrators and legislators to
support screening programs.AIDS Research and Treatment 5
Table 1: Comparison of opt-in and opt-out patients.
Characteristic
Accepted opt-in
screening
(n = 4,061), n (%)
Accepted opt-out
screening
(n = 6,273), n (%)
P valuea
Surveyed opt-in
screening
(n = 207), n (%)
Surveyed opt-out
screening
(n = 188), n (%)
P valuea
Gender
Male 2,103 (52) 3,319 (53) 0.264 102 (49) 119 (63) 0.005
Female 1,958 (48) 2,954 (47) 105 (51) 69 (37)
Age (years), mean SD 38 ± 13 38 ± 13 >0.999b 37 ± 13 39 ± 13 0.128b
Race/ethnicity
Black 1,625 (40) 2,862 (46) <0.001 77 (37) 88 (47) 0.883
White 563 (14) 859 (14) 28 (14) 29 (15)
Hispanic 1,262 (31) 1,826 (29) 77 (37) 53 (28)
Other 611 (15) 726 (12) 25 (12) 18 (10)
Education level
Some high school na na 63 (30) 49 (26) 0.747
High school graduate na na 67 (32) 67 (36)
Some college na na 52 (25) 53 (28)
College degree na na 18 (9) 15 (8)
Unknown na na 7 (3) 4 (2)
Health insurance
No insurance na na 141 (68) 145 (77) 0.076
Public insurance na na 45 (22) 35 (19)
Private insurance na na 9 (4) 2 (1)
Unknown na na 12 (6) 6 (3)
Relationship status
Single na na 97 (47) 119 (63) 0.009
Married/partnered na na 63 (30) 37 (20)
Divorced/separated na na 46 (22) 32 (17)
Unknown na na 1 (0.5) 0
Reported risk past 12 months
Heterosexual sex na na 142 (69) 126 (67) 0.532
MSM only na na 5 (2) 7 (4)
IDU only na na 2 (1) 6 (3)
MSM + IDU na na 1 (0.5) 1 (0.5)
None na na 57 (28) 48 (26)
Previous HIV test
Yes na na 120 (58) 113 (60) 0.667
No na na 87 (42) 75 (40)
aPearson Chi-square.
bt-test.
Abbreviations: na: not available; MSM: men sex with men; IDU: injection drug use.
We demonstrate that patient satisfaction is similar with
opt-in and opt-out HIV screening protocols in an urban ED.
Over 95% of patients surveyed reported being satisﬁed with
HIV testing and would recommend the ED as a testing site.
Brown et al. also assessed patient perceptions with routine
opt-out HIV screening and similarly showed that over 90%
ofEDpatientssurveyedwould“recommendtoafriendtoget
an HIV test in the ER” and that over 3/4 of patients felt that
“the ER is a good place to perform screening” [18].
Patients in both screening phases rated their overall ex-
perience with HIV screening favorably. However, individuals
surveyed during the opt-in phase of the study were more
likely to report their overall experience as excellent. The rea-
son for this diﬀerence between the two phases is unknown,
but it may be explained by the extra time the HIV testers
spent with the patients reviewing the consent form during
theopt-intestingphaseorthemannerinwhichpatientswere
consented for testing.6 AIDS Research and Treatment
Table 2: Patient satisfaction with HIV screeninga, n = 393.
Screening
Excellent Very good Good Fair Poor
n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI)
Opt-in
All 130/206 63.1 (56.5–69.7) 30/206 14.6 (9.7–19.4) 36/206 17.5 (12.3–22.7) 9/206 4.37 (1.6–7.2) 1/206 0.5 (0–1.4)b
Negative 129/198 65.2 (58.5–71.8) 29/198 14.7 (9.7–19.6) 31/198 15.7 (10.6–20.7) 8/198 4.04 (1.3–6.8) 1/198 0.5 (0–1.5)b
Positive 1/8 12.5 (0–35.4)a 1/8 12.5 (0–35.4)a 5/8 62.6 (29.0–96.1) 1/8 12.50 (0–35.4)b 0/8
Opt-out
All 91/187 48.7 (41.5–55.8) 54/187 28.9 (22.4–35.4) 30/187 16.0 (10.8–21.3) 11/187 5.9 (2.5–9.3) 1/187 0.5 (0–1.6)b
Negative 83/159 52.2 (44.4–60.0) 45/159 28.3 (21.3–35.3) 21/159 13.2 (8.0–18.5) 10/159 6.3 (2.5–10.1) 0/159
Positive 8/28 28.6 (11.8–45.3) 9/28 32.1 (14.8–49.4) 9/28 32.1 (14.8–49.4) 1/28 3.6 (0–10.4) 1/28 3.6 (0–10.4)b
aThe global index of satisfaction was determined by asking the patient, “Overall, how would you rate the rapid HIV testing program in the emergency
department?”
b1-sided, 97.5% CI.
Abbreviation: CI: conﬁdence interval.
We also demonstrate that patient attitudes over a wide
variety of domains are similar between opt-in and opt-out
HIV screening protocols. Importantly, patients did not re-
port feeling coerced to test and maintained their autonomy
in deciding whether to be tested, even with the opt-out
methodology. Preserving patient perception of autonomy
with opt-out HIV screening is important because this has
been cited as a major concern with the revised CDC
guidelines [7].
Additionally, this study provides more detailed data
about patient satisfaction with streamlined ED screening
thananypriorstudy.Thestreamlinedformateliminatedpre-
test counseling (providing instead a pretest information bro-
chure) and simpliﬁed negative posttest counseling. Despite
thestreamlinedapproach,patientswereremarkablysatisﬁed,
and most patients felt the information provided to them was
adequate.Thisisconsistentwiththeresultsofanothersurvey
studythatassessedEDpatientacceptanceandunderstanding
of opt-in and opt-out HIV testing [19]. Of 529 respondents,
approximately 2/3 felt that counseling was unnecessary both
before testing and after receiving a negative HIV test. While
the majority of patients in both study phases did not want
additional counseling, patients surveyed during the opt-in
phase were more likely to desire an in-depth discussion
regarding HIV. The reason for this diﬀerence is not known;
however, one possibility is that the more thorough consent-
ing process with the HIV tester during the opt-in phase
generated an additional desire for information in a small
number of the patients surveyed.
The generalizability of our results to other screening
programs is not known. Our method of implementing
opt-out HIV screening represents one of several methods.
Because California state law requires documentation of pa-
tient refusal of HIV screening, we added an opt-out sig-
nature box to the general consent form—essentially creat-
ing an abbreviated written consent for patients to sign
if they decline. Additionally, we chose to soften the opt-
out language, instructing patients that HIV testing may be
done unless they decline. This interpretation of opt-out
screening may not be fully consistent with the intent of the
CDC recommendations. Patient satisfaction and attitudes
toward opt-out HIV screening may be somewhat diﬀerent
in institutions that implement diﬀerent models of opt-out
screening.
This study has several limitations. Although the survey
instrument was developed using standard methodology and
pilot tested on a small convenience sample of subjects and
reﬁned with their feedback, the instrument has not been
validated elsewhere. Additionally, content validity was not
formally assessed, and participants may have misunderstood
particular survey questions leading to biased results.
Convenience sampling and the relatively small surveyed
population (approximately 5% of screened patients) may
have resulted in selection bias. Furthermore, not including
patients who declined HIV screening may have inﬂuenced
the ﬁndings, probably toward higher satisfaction ratings
[18]. The research volunteers who administered the survey
were not blinded to the study purpose, and the study was not
self-administered. Although research assistants were trained
to remain neutral when presenting the survey, the inﬂuence
of the Hawthorne eﬀectmayhavefurtherbiasedrespondents
to favorable ratings.
Because we evaluated only those patients who completed
HIV screening, the results may lack generalizability. We did
not assess how nontesters felt about the testing method, and
we were therefore unable to determine whether the testing
methodology inﬂuenced a patient’s decision not to test.
We did not evaluate patient comprehension of the opt-
in and opt-out screening protocols, and we are unable to
report whether patients misunderstood the opt-out consent
process. Because we utilized point-of-care rapid HIV testing
using dedicated HIV testers and oral ﬂuid sampling, it
is unlikely that patients were tested unknowingly—even if
some patients may have initially misunderstood the consent
process. This may not hold true for programs, however,
that link acceptance of opt-out HIV screening at registration
with testing on blood samples later obtained as a part of
ED care. Determining patient comprehension of opt-out
HIV screening, speciﬁcally when HIV consent is integrated
into the general consent for care, should be evaluated inAIDS Research and Treatment 7
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future studies to ensure that patients are not tested un-
knowingly.
5. Conclusions
Our results suggest that, among the subset of ED patients
surveyed, satisfaction with HIV screening is high, regardless
of whether opt-in or opt-out screening is implemented.
Furthermore, patients did not feel coerced into testing and
patient autonomy was preserved even with opt-out methods
and elimination of separate written consent. These results
may encourage more widespread implementation of opt-out
HIV screening in EDs.
Disclaimer
The ﬁndings and conclusions in this article are those of the
authors and do not necessarily represent the views of the
CDC.
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